Work

Assessment of Antiangiogenic Effect Using 99m Tc-EC-Endostatin

Year: 2002

Type: article

Source: Cancer Biotherapy and Radiopharmaceuticals

DOI: 10.1089/108497802753773856

Authors: David J. Yang, Kil-Dong Kim, Naomi R. Schechter, Dong-Fang Yu, Peng Wu, Ali Azhdarinia, Jennifer S. Roach, Saady K. Kalimi, Kaoru Ozaki, William E. Fogler, Jerry L. Bryant, Roy Herbst, James Abbruzzes, E. Edmund Kim, Donald A. Podoloff

Institutions: The University of Texas MD Anderson Cancer Center, CASI Pharmaceuticals (United States)

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: John S. Dunn Foundation, National Institutes of Health, National Cancer Institute

Awards: G1619438925, Cancer Center Support Grant

OpenAlex ID: W2037752525

FWCI: 1.944

Cites: 53

Cited by: 45

Related to: 10